drugset / Trial / NCT01210404

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

NCT01210404

Phase 1 Completed 12 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Filibuvir, a CYP3A4 inhibitor is being developed for the treatment of chronic Hepatitis C infection. Given the likelihood of co administration of filibuvir and methadone, this study will evaluate the effect of filibuvir on the pharmacokinetics of R/S Methadone.

Timeline

Start
2011-02
Primary completion
2011-05
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Filibuvir Small molecule 600 mg
Subject Methadone Other / unclassified